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ABSTRACT
The big challenge for the detection of pharmaceutical residues in water samples is the type of ionization mode in 
terms of positive or negative ionization which plays an important role to identify and quantify the analytes using liquid 
chromatography/mass spectrometry. An analytical method was applied to analysis of gliclazide (diabetic drug) in surface 
water and wastewater from sewage treatment plants and hospitals. The proposed analytical method allows simultaneous 
isolation and concentration procedure using solid phase extraction (Oasis HLB) prior to separation using high-performance 
liquid chromatography. The detection and confirmation was achieved by applying time-of-flight analyzer. The limits of 
quantification were as low as 1.4 ng/L (deionized water), 4 ng/L (surface water), 27 ng/L (hospital influent), 10 ng/L 
(hospital effluent), 6 ng/L (sewage treatment plant effluent) and 21 ng/L (sewage treatment plant influent), respectively. On 
average, good recoveries of higher than 87% were obtained for gliclazide in the studied samples. The proposed method 
successfully determined and quantified gliclazide in surface water and wastewater. The results showed that gliclazide 
is a persistent compound in sewage treatment effluents as well as in the recipient rivers. Gliclazide was detected in all 
samples and the highest concentration was 130 ng/L in influent of sewage treatment plant. 
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ABSTRAK
Antara cabaran besar untuk mengesan sisa farmasi dalam sampel air menggunakan kromatografi cecair/spektrometri jisim 
adalah jenis mod pengionan, dengan pengionan positif atau negatif memainkan peranan yang penting untuk mengenal 
pasti dan menilai kandungan analit. Suatu kaedah analisis telah diaplikasikan untuk menganalisis gliklazida (ubat 
diabetik) dalam air permukaan dan juga air buangan dari loji rawatan kumbahan dan hospital. Kaedah analisis yang 
digunakan membolehkan prosedur pengasingan dan pemekatan dijalankan serentak menggunakan pengekstrakan fasa 
pepejal (Oasis HLB), iaitu teknik pemisahan dengan menggunakan kromatografi cecair berprestasi tinggi. Pengesanan 
dan pengesahan telah dicapai dengan menggunakan penganalisis masa penerbangan. Had kuantifikasi adalah serendah 
1.4 ng/L (air ternyahion) 4 ng/L (air ternyahion),  27 ng/L (influen hospital), 10 ng/L (efluen hospital), 6 ng/L (efluen loji 
rawatan sisa kumbahan) dan 21 ng/L (influen loji rawatan kumbahan). Secara keseluruhannya, peratusan perolehan 
semula yang baik diperoleh untuk gliklazida dalam sampel yang dikaji iaitu melebihi nilai 87%. Kaedah yang dicadangkan 
berjaya menentukan secara kuantitatif kandungan gliklazida dalam air permukaan dan air sisa buangan. Hasil kajian 
menunjukkan bahawa gliklazida adalah sebatian kekal dalam efluen rawatan kumbahan dan juga di dalam sungai. 
Gliklazida telah dikesan dalam kesemua sampel dan kepekatan maksima ialah 130 ng/L dalam influen loji rawatan sisa 
kumbahan.
Kata kunci: Efluen hospital; gliklazida; pengekstrakan fasa pepejal; pengionan positif
INTRODUCTION
Pharmaceuticals have become recognized as relevant 
environmental contaminants in the course of the last 
decade. However, gliclazide is one of the diabetic-
pharmaceuticals which are used to treat diabetes type 
2 (non-insulin dependent diabetes mellitus) (Drugbank 
2012). In Malaysia, gliclazide (C15H21N3O3S) was used 
increasingly in last few years hence; the consumption rate 
was 11373 kg/year in 2008 compared with 2005 which 
was 3083 kg/year (MOH 2012). Human pharmaceuticals 
enter the environment mainly through their therapeutic 
use. Metabolites of pharmaceuticals (parent or conjugated 
compounds) are excreted via urine or feces will play a 
main role to pollute the aquatic environment because the 
end point of all these compounds will be the surface water 
(Al-Aukidy et al. 2012; Grabic et al. 2012; Koo et al. 2010; 
Payán et al. 2010). Because of the high to mid polarity of 
pharmaceuticals, liquid chromatography (LC) is the best 
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choice to separate the individual compounds. To detect the 
pharmaceuticals in the environment, powerful analytical 
methods are needed because the very low concentration 
of these compounds in water (nano gram per liter – few 
micro gram per liter). For the detection purposes, modern 
advanced mass spectrometry is needed to discriminate 
between multiple pharmaceuticals and interfering matrix 
compounds and to obtain sufficient sensitivity. At present, 
a high selectivity, sensitivity and accuracy instrument was 
used for this purpose which is liquid chromatography/ 
time-of-flight/ mass spectrometry (LC-TOF/MS) (Ferrer & 
Thurman 2012; Martin et al. 2011; Petrovic et al. 2006). 
One challenge accompanied analysis of gliclazide in water 
is type of ionization mode either positive or negative 
modes. However, the chemical structure of analyte and 
functional group on the structure will help to determine 
the type of ionization. The aim of this study is to develop a 
sensitive and efficient method for the analysis of gliclazide 
in influent and effluent of wastewater as well as surface 
water using LC-TOF/MS.
MATERIALS AND METHODS
CHEMICALS AND MATERIALS
Pure standard (≥98%) of gliclazide (GLZ) (CAS no. 
21187-98-4), was purchased from Sigma-Aldrich (USA). 
Deionized water (DW) used was supplied by EASYPure 
RODI (USA). HPLC-grade methanol (MeOH), acetonitrile 
(ACN), acetone and formic acid (FA) were supplied by 
Merck (Germany). Methyl tertiary butyl ether (MTBE) 
was supplied by J. T. Baker (USA). The cartridges used 
for solid phase extraction were Oasis HLB (3cc, Waters, 
USA). Individual stock standard solutions (1000 mg/L) 
were prepared in HPLC-grade MeOH and stored at 18°C 
to minimize the degradation of the standard. A working 
solution of gliclazide standard was prepared by appropriate 
dilution of the stock solution. Further dilutions of the 
working solution were prepared in MeOH-DI (1:9, v/v) 
before each analytical run. Prior to use, all glassware were 
boiled with water at 100°C, rinsed with distilled water, 
dried in an oven at 200°C for 2 h, subsequently rinsed with 
MeOH, and dried in the oven at 200°C for 2 h.
SAMPLE PREPARATION
Samples of influent and effluent of sewage treatment plants 
(STPs) and hospitals (HSPs), and surface water (SW) were 
collected from Negeri Sembilan state which is one of the 
thirteen states in Malaysia as presented in Figure 1. All 
samples were collected in 1 L amber glass bottles with 
Teflon-lined and sequentially preserved by adding 1 g/L 
of sodium azide to prevent microbial degradation. Samples 
were filtered through a 0.7 µm GF/F filter from Whatman 
(UK) to remove particulate matter in water samples. The 
samples were stored at 4°C until SPE extraction, which was 
performed within 24 h in order to avoid any degradation. 
The extraction protocol was provided by Al-Qaim et al. 
(2014). SPE cartridges with different packing materials 
namely HLB, SAX, ENV and MCX were tested for the best 
recovery of the analyte. The cartridges were installed on 
a vacuum manifold and sequentially pre-conditioned with 
FIGURE 1. Map to describe all sampling points
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2 mL MTBE, 2 mL MeOH, and 2 mL DI  at flow rate 1.0 
mL/min. Then, the samples (100 mL STP, HSP influent, 250 
mL STP, HSP effluent and 1000 mL surface water) were 
passed through the cartridges at a flow rate of 9 mL/min 
under vacuum conditions. Subsequently, the cartridges 
were rinsed with 2 mL DI  prior the elution. Cartridges 
were dried under vacuum at 15 mL/min for 25 to 30 min 
to remove residual water. Finally, cartridges were eluted 
using three successive aliquots of 5×1 mL MTBE, 2×1 mL 
acetone-MeOH (21:9, v/v), and 3×1 mL acetone-MeOH 
(9:21, v/v). The elute solution were collected in a 12 mL 
collection tube and concentrated to dryness under a gentle 
stream of N2 gas. Dry extracts were reconstituted to 500 µL 
with MeOH-DIW (10:90, v/v) and then transferred to 
250 µL deactivated glass insert with polymer feet inserted 
in amber glass vials from Agilent Technologies (USA). The 
extract (30 µL) was automatically injected into LC-ESI-TOF/
MS system for analysis.
LIQUID CHROMATOGRAPHY-TIME-OF-
FLIGHT/MASS SPECTROMETRY
Gliclazide was separated using a Dionex Ultimate 3000/LC 
09115047 (USA) system equipped with a vacuum degasser, 
a quaternary pump, and an autosampler. Sample aliquots of 
30 µL were injected to 5 µm, 2.1 mm × 250 mm Thermo 
Scientific C18 column. ESI source was utilized as ionization 
source. Gliclazide was analyzed in positive ionization 
(PI) mode and eluted off the column with a mobile phase 
consisting of (A) 0.1% FA in DI and (B) ACN-MeOH (3:1, 
v/v) at 0.3 mL/min. The elution started at 5% B and was 
then linearly increased to 60% B over 3 min, further 
increased to 97% B over 3 min and then kept isocratic for 5 
min. Next, the elution was returned to its starting conditions 
over 11.1 min and allowed to equilibrate for 5 min prior 
to the next run. Mass spectrometry was performed on 
ESI(+)/TOF instrument (µTOF-Q, Bruker/Germany). The 
results were obtained with the following settings: MS 
capillary voltages, 4000/3500 (PI/NI); drying-gas flow rate, 
8.0 L/min; drying gas temperature, 190°C; and nebulizer 
pressure, 4.0 bar. The accurate mass was calculated using 
software Daltonics DataAnalysis incorporated in the 
instrument.
METHOD VALIDATION
Gliclazide was identified based on its mass value (m/z) and 
retention times. Quantification was carried out using the 
TOF mode by extracting the narrow window extracted ion 
chromatogram (nwXIC) of the molecular ion for gliclazide 
(typically extracted using a 20 mDa window) compared 
with previous studies that used 20 and 50 mDa windows 
(Ferrer & Thurman 2012; Petrovic et al. 2006). Positive 
identification of gliclazide was based on (a) accurate mass 
measurement of the base ion with an error of −0.6 ppm for 
gliclazide which falls within the widely accepted accuracy 
compared with a previous study (Petrovic et al. 2006) and 
(b) LC retention time of the analyte compared with that of 
a standard with an error of ≤ ± 0.1% for gliclazide. The 
instrumental quantification limit (IQL) was estimated from 
the injection of a standard solution successively diluted 
until reaching a concentration level corresponding to an 
S/N ratio ≥10. Calibration curve was generated by injecting 
pooled solutions prepared from the standard solution (0.3 
μg/L-3 mg/L). The curve was constructed for gliclazide 
by plotting the peak area of against the concentration 
of gliclazide using linear regression analysis and the 
concentration range that gave good fit (determination 
coefficients, R2 = 0.993). The limit of quantification 
(LOQ) for the entire method in the different matrices was 
calculated using the following (1) (Vieno et al. 2006).
 LOQ =    (1)
where IQL is the instrumental quantification limit (ng/L); 
R% is  is the recovery of the analyte in the corresponding 
matrix; and  CF is the concentration factor (2000, 1000, 
500 and 200 for DW, SW, STP and HSP effluent and STP 
and HSP influent, respectively). In order to determine the 
recoveries in different matrices, DW, SW, STP effluent 
and HSP influent were spiked with a standard solution 
of gliclazide and enriched using SPE. Six replicates were 
performed on the different days and the spiking level 
was 0.5, 1, 2 and 5 μg/L for DW, SW, STP effluent and 
HSP influent, respectively. The different spiking level was 
applied because different matrix sample was tested. The 
varying in spiking levels was due to type of the sample 
in terms of complexity of the sample so low spiking level 
for less complexity sample and vice versa. The recoveries 
were evaluated by comparing the solid phase extracted 
samples to non-extracted standard solutions (i.e. standards 
dissolved in the solvent). Recoveries (R%)  was calculated 
based on (2) below.
 R% =   (2)
where Asp is the peak area of the analyte in the solid phase 
extracted sample; Aun is peak area in the un-spiked water 
sample; and Asol is the peak area in the solvent. 
RESULTS AND DISCUSSION
OPTIMIZATION OF IONIZATION MODE AND 
COLLISION ENERGY
The optimized modes of positive ionization (PI) and 
negative ionization (NI) were properly selected to quantify 
gliclazide in real samples. It was found that at positive 
ionization mode the signal to noise ratio of gliclazide was 
very high compared with negative ionization mode as 
presented in Figure 2(a).
 This fact is approved by our previous study which 
means gliclazide was not detected in surface water and 
waste water samples using negative ionization analysis (Al-
Qaim et al. 2014). However, the positive ionization mode 
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is the most appropriate choice to analysis of gliclazide in 
water samples.
 Collision energy was studied from 2 to 30 eV to identify 
the optimum value for gliclazide. Figure 2(b) shows that 
signal to noise ratio for gliclazide was increased steadily 
until 10 eV then decreased with increasing the collision 
energy. Hence, the optimum collision energy is 10 eV. The 
variation in fragmentation of gliclazide at 10 and 30 eV was 
presented in Figure 2(c). At 30 eV, some fragmentations 
were observed in terms of extra peaks with different m/z 
which mean high collision energy force gliclazide to be 
more fragmented resulting to reduce limit of detection.
EVALUATION OF DIFFERENT CARTRIDGES AND 
OPTIMIZATION OF ELUTING SOLVENT AND FLOW 
RATE OF SAMPLE LOADING
Different cartridges were used to study the recovery of 
gliclazide, including mixed-mode cationic exchange (MCX), 
SupelcleanTM ENVI-Chrom P (highly cross-linked, neutral, 
specially cleaned styrene divinylbenzene co-polymer 
resin used to retain hydrophobic compounds with some 
hydrophilic functionality under reversed phase conditions), 
Oasis HLB cartridges (universal polymeric reversed-phase 
sorbent) and SupelcleanTM LC-SAX (quaternary amine, 
Cl− counter-ion, ion exchanger and reverse–phase sorbent 
cartridge). As can be observed from Figure 3(a), the highest 
recovery was accompanied by Oasis HLB cartridge may due 
to the suitability of this sorbent to extract a wide range of 
acidic, basic and neutral compounds as reported in different 
previous papers (Gómez et al. 2007; Lajeunesse & Gagnon 
2007; Petrovic et al. 2014; Weigel et al. 2004). Otherwise, 
MCX cartridge exhibited the lowest recovery to retain 
gliclazide at neutral pH. Gliclazide was extracted efficiently 
with MCX at acidic conditions may due to protonation of 
amino group on its structure as reported by previous study 
(Al-Odaini et al. 2010) to make it suitable for MCX cartridges. 
FIGURE 2. Optimization of (a) ionization mode (b) collision energy and 
(c) mass fragment for detection of gliclazide
(a)
(b)
(c)
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 The extraction of gliclazide using Oasis HLB cartridge 
requires an efficient elution solvent to elute it. Hence, four 
elution solutions were optimized by using combination of 
different ratio solvents namely elution A (Elu A), B (Elu B), 
C (Elu C) and D (Elu D). Elu A consist of mixture MTBE 
(5×1 mL) plus MeOH (5×1 mL); Elu B: DCM (5×1 mL) plus 
acetone-MeOH (21:9, v/v) (2×1 mL) plus acetone-MeOH 
(9:21, v/v) (3×1 mL); Elu C: MTBE (5×1 mL) plus acetone-
MeOH (21:9, v/v) (2×1 mL) plus acetone-MeOH (9:21, 
v/v) (3×1 mL); Elu D: acetone-MeOH (21:9, v/v) (5×1 mL) 
plus acetone-MeOH (9:21, v/v) (5×1 mL). As noticed from 
Figure 3(b), Elu C was selected as the best eluent solvent 
in which gliclazide gave the highest recovery, wherein, 
the lowest recovery was achieved with Elu A and Elu D. 
Hence, a moderately polar such as acetone is considered 
more effective with non-polar solvent such as MTBE to 
get a good recovery for further analysis of real samples. 
Therefore, Elu C was selected as the best elution solvent. 
 Flow rate of loading was also considered in this study. 
Indeed, the principle of optimization of flow rate to elute 
the analytes from SPE cartridge is based on same principle 
of using chromatographic column i.e. a relation between 
flow rate and binding of analytes on sorbent. In order to 
evaluate this issue, three flow rates were tested: 1-1.5, 3-3.5 
and 9-9.5 mL/min, respectively. The increasing flow rate 
will reduce the force between the analyte and the sorbent, 
then increasing the elution strength. Figure 3(c) shows the 
best recovery for gliclazide at 9-9.5 mL/min.
STUDY ON THE MATRIX EFFECTS AND 
EXTRACTION EFFICIENCY
The entire method was validated for DW, SW and the HSP and 
STP effluents and influents. Recovery studies were performed 
by spiking standard gliclazide to DW, SW, STP effluent and 
HSP influent at different concentration levels of 0.5, 1, 2 and 
5 µg/L, respectively, because the water samples are different 
in terms of pollution level and matrix effects. Therefore, 0.5 
µg/L was selected for very clean water (DW), in contrast 5 
µg/L was selected to very polluted sample (influent of HSP 
and/or STP). The recoveries and other validation parameters 
are presented in Table 1.
 Gliclazide was relatively well-recovered in all sample 
matrices (% Recovery ≥ 72%) for all samples except for 
influent in both STP and HSP which was 142 and 45%, 
respectively. The differences in the recoveries among sample 
matrices are considered reasonable because the samples are 
varied in terms of level of pollution. Thus, this method can 
be considered acceptable for extracting gliclazide using 
solid phase extraction as compared with other previous 
studies (Al-Odaini et al. 2010). Evaluation on the matrix 
effects (ME%) on signal intensity using SPE extracts of 
water samples spiked with pharmaceuticals (spike level of 
200 µg/L). The spiked samples were injected to LC-ESI-TOF/
MS. The matrix effect was calculated using (3).
 ME% =   (3)
where Asol is the peak area of the analyte in the solvent; Asp 
is the peak area in the spiked matrix extract (after drying 
with N2 gas prior to injection); and Aun is the peak area in 
the un-spiked matrix extract. In this procedure, the analyte 
losses caused by ionization can be evaluated, but any losses 
caused by SPE and further sample preparation are excluded. 
From (3), the effect of sorbent is negligible, so that only the 
effect of matrix is considered. All results were presented in 
our previous study (Al-Qaim et al. 2010), which indicates 
a varying matrix effects ranged from 31-66% was observed 
based on the type of sample.
METHOD VALIDATION
The linearity of the external calibration curve was 
evaluated for gliclazide standard by statistical methods 
measuring the coefficient of determination (R2), which 
quantify the goodness of fit of the linear regression. The 
LC-ESI-TOF/MS method exhibits excellent linearity (R2 = 
FIGURE 3. Detection of gliclazide based on selection 
(a) cartridge (b) elution solvent and (c) flow rate
(a)
(b)
(c)
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0.993) for gliclazide with range of 0.3 μg/L to 3 mg/L. 
Gliclazide showed low instrument quantification limits 
(IQL) in the aqueous samples using positive ionization 
mode compared to negative ionization mode which 
exhibits high IQL. The IQL was determined to be the 
concentration with S/N ratio ≥10 which is 0.3 µg/L. The 
LOQs over the entire method were calculated using (1), 
it was ranged from 1.4 to 27 ng/L in all water samples 
as shown in Table 1. Higher LOQs were observed for 
gliclazide in STP and HSP influent and effluent because of 
the signal suppression within these matrices.
ANALYSIS OF REAL SAMPLES
In order to evaluate the applicability of the developed 
method, water samples collected from STP influent and 
effluent, HSP influent and effluent and surface water 
were analyzed. Figure 4 shows the powerful of LC-TOF/
MS in terms of the extracted ionic chromatogram (ESI) of 
gliclazide against total ionic chromatogram (TIC). 
 Results of real samples analysis are presented in Figure 
5. Gliclazide was found in surface water at relatively 
high concentrations of 15 ng/L. The lowest detected 
concentration was 6 ng/L in the surface water. For the 
TABLE 1. Method validation parameters
Method validation
Type of samples
DW SW INF STP EFF STP INF HSP EFF HSP
LOQ (ng/L)
Recovery % ± SD n = 6
1.4
93±18
4
72±19
21
142±8
6
75±28
27
45±11
10
97±14
Instrumental validation parameters
Linearity (R2)
0.993
Equation
y = 2687× − 9402
IQL (μg/L)
0.3
FIGURE 4. Extracted ion chromatogram (EIC) vs total ion chromatogram 
(TIC) for analysis of gliclazide in real sample using LC-ESI (+) TOF/MS
FIGURE 5. Concentration (ng/L) of gliclazide in all water samples using PI mode
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hospital effluents, gliclazide was detected at the highest 
concentrations of 26 ng/L. The lowest concentration 
detected was 16 ng/L. In case of effluent of sewage 
treatment plants, the range of concentration was 17-40 ng/L 
while in the influent of sewage treatment plant, the range 
of concentration was 49-60 ng/L. These results showed 
gliclazide was persistent after treatment either in sewage 
treatment plants (ditch and pond oxidation treatment) or in 
hospital sewage treatment plants (biological treatment). In 
our previous study, gliclazide was not detected in all water 
samples using negative ionization mode, hence the high 
frequency of detection for gliclazide may be attributed to the 
best selection of ionization which means positive ionization 
mode in this present study (Al-Qaim et al. 2014, 2013).
CONCLUSION
A methodology using LC-TOF/MS for the analysis of 
gliclazide was developed and successfully applied to 
determine gliclazide in different environmental aquatic 
samples. Ionization mode is considered a power tool to 
enhance the detection limit. Consequently, gliclazide was 
detected in positive ionization mode but it was not detected 
in negative ionization mode. TOF/MS is a very sensitive 
detector and can detect extremely low concentrations 
(ng/L) in actual samples with high accuracy and high 
resolution in terms of m/z value. LOQ varied broadly 
depending on the water sample which is ranged from 1.4 
to 27 ng/L. 
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